Unlocking
the future
of medicine

About us

Offering an unrivalled modular platform and tailored hyper-targeting is how we stand apart

Pipeline

Reducing the impact of cancer and autoimmune diseases on people’s lives is why we’re here

Innovation and research

Pushing the boundaries of human advancement in medicine is what drives us every day

Investors
 
 
 

A vaccine platform that unlocks unlimited possibilities for the future of medicine

The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.

Highlights

Nykode Therapeutics – invitation to Q4 2023 financial results ...

Read More
22 February 2024

42nd Annual J.P. Morgan Healthcare Conference, January 10, 2024 ...

Read More
10 January 2024

Nykode Therapeutics to Present at the 42nd Annual J.P. ...

Read More
19 December 2023

DNB Nordic Healthcare Conference, December 14, 2023 – presentation

Read More
14 December 2023

Nykode Therapeutics Announces Expansion of Oncology Pipeline Aiming to ...

Read More
14 December 2023

Jefferies Healthcare Conference, November 16, 2023 – presentation

Read More
17 November 2023

Nykode Therapeutics – 3Q 2023 Financial Results – presentation

Read More
15 November 2023

Nykode Therapeutics reports 3Q 2023 Financial Results

Read More
15 November 2023

Nykode Therapeutics – invitation to Q3 2023 financial results ...

Read More
09 November 2023